Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care

BACKGROUND: Results of cardiovascular outcome trials enabled a shift from “treat-to-target” to “treat-to-benefit” paradigm in the management of type 2 diabetes (T2D). However, studies validating such approach are limited. Here, we examined whether treatment according to international recommendations...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, Mario Luca, Longato, Enrico, Di Camillo, Barbara, Sparacino, Giovanni, Avogaro, Angelo, Fadini, Gian Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738028/
https://www.ncbi.nlm.nih.gov/pubmed/36494815
http://dx.doi.org/10.1186/s12933-022-01712-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738028/
https://www.ncbi.nlm.nih.gov/pubmed/36494815
http://dx.doi.org/10.1186/s12933-022-01712-4

Ejemplares similares